Repurposing dronedarone for colorectal cancer therapeutic via suppression of the AKT/ERK signaling pathways
- 16 January 2026
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 246, 117715
Abstract
No abstract availableKeywords
Funding Information
- Lanzhou Science and Technology Bureau (2025-2-100)
- Lanzhou Science and Technology Bureau (2024-4-2)
- Lanzhou Science and Technology Bureau (2025-2-103)
- Lanzhou University (20250260020)
- Lanzhou University (20250260016)
- Lanzhou University (20250260006)
This publication has 58 references indexed in Scilit:
- Dissecting the novel abilities of aripiprazole: The generation of anti-colorectal cancer effects by targeting Gαq via HTR2BActa Pharmaceutica Sinica B, 2023
- Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienonesBioorganic & Medicinal Chemistry, 2022
- Aspirin Use and Risk of Colorectal Cancer Among Older AdultsJAMA Oncology, 2021
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of actionMedicinal Research Reviews, 2017
- Colorectal cancer-derived tumor spheroids retain the characteristics of original tumorsCancer Letters, 2015
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer GrowthCancer Cell, 2007
- FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in miceNaunyn-Schmiedeberg's Archives of Pharmacology, 2006
- Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmiasProgress in Cardiovascular Diseases, 1989